{"id": "1357903826083143688", "creation": 1612584475.0, "user_id": "1174335540130279425", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "The Subject Expert Committee of India's central drug regulatory authority has given a go-ahead to the @SerumInstIndia to conduct Phase 2 and 3 clinical trials for #Novavax #CovidVaccine candidate in the country.\n\n#seruminstituteofindia #Covid19 #vaccine \n\nhttps://t.co/vuQSxinAUt", "first_save": 1634559108.199414, "hashtags": ["#NOVAVAX", "#COVIDVACCINE", "#SERUMINSTITUTEOFINDIA", "#COVID19", "#VACCINE"]}